Skip to main content

Crescent Biopharma, Inc 10-K for FY2022

Crescent Biopharma, Inc. (CBIO)

10-K 2023-03-29 For: 2022-12-31
View Original
Added on April 10, 2026

About this 10-K

Crescent Biopharma, Inc filed this 10-K on March 29, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$75K
down 93.5% from $1.16M a year earlier
Net loss
$46.69M
compared with a net loss of $63.43M a year earlier
Diluted EPS
-$0.89
compared with -$1.23 a year earlier